APA (7th ed.) Citation

AM, D., P, Y., E, Z., J, N., L, X., Jr, M. T., . . . SJ, C. (2021). Hemostatic Efficacy and Anti-FXa (Factor Xa) Reversal With Andexanet Alfa in Intracranial Hemorrhage: ANNEXA-4 Substudy. Stroke, 52(6), 2096. https://doi.org/10.1161/STROKEAHA.120.030565

Chicago Style (17th ed.) Citation

AM, Demchuk, et al. "Hemostatic Efficacy and Anti-FXa (Factor Xa) Reversal With Andexanet Alfa in Intracranial Hemorrhage: ANNEXA-4 Substudy." Stroke 52, no. 6 (2021): 2096. https://doi.org/10.1161/STROKEAHA.120.030565.

MLA (9th ed.) Citation

AM, Demchuk, et al. "Hemostatic Efficacy and Anti-FXa (Factor Xa) Reversal With Andexanet Alfa in Intracranial Hemorrhage: ANNEXA-4 Substudy." Stroke, vol. 52, no. 6, 2021, p. 2096, https://doi.org/10.1161/STROKEAHA.120.030565.